study question: Does prenatal exposure to perfluoroalkyl substances (PFASs) have long-term effects on female reproductive function?. summary answer: Our results suggest an association between in utero exposure to perfluorooctanoic acid (PFOA) and delay in age of menarche.
Introduction
Perfluorooctanoic acid (PFOA) and perfluorooctane sulphonic acid (PFOS) are members of a family of synthetic perfluoroalkyl substances (PFASs) that have been extensively used in a variety of industrial and consumer products for more than half a century. PFOA and PFOS are highly persistent in the environment and have long half-lives in humans (Lau et al., 2007; Buck et al., 2011) . PFASs can be measured in general populations all over the world and PFOA and PFOS are especially widely detected (Lau et al., 2007; Olsen et al., 2009) . The primary exposure route for PFOA and PFOS is through ingestion of contaminated food and drinking water but house dust and indoor air also contribute to human exposure (Haug et al., 2011) . Concern has been raised regarding adverse health effects of PFASs including effects on the reproductive system . This is supported by findings from animal toxicology studies with effects on female reproduction including altered ovarian function, histopathologic changes in the reproductive tract and delay in vaginal opening and in development of mammary gland tissue (Yang et al., 2009; White et al., 2011a,b; Dixon et al., 2012; Zhao et al., 2012) .
Epidemiological data on possible effects of PFASs on female reproductive health originate primarily from cross-sectional studies. Fei et al. (2009) used data from the Danish National Birth Cohort and observed an association between higher serum levels of PFOA and PFOS in pregnant women and a longer waiting time to pregnancy. The authors concluded that exposure to PFOA and PFOS in levels found in the general population may reduce fecundity (Fei et al., 2009 (Fei et al., , 2012 . However, this is not or only partly consistent with results from other cohorts (Vestergaard et al., 2012; Whitworth et al., 2012; Buck Louis et al., 2013) . Besides time to pregnancy, end-points of female reproductive health have only been investigated sparsely. In the above-mentioned study by Fei et al. (2009) , an association between PFAS levels and irregular menstrual cycles was found. A study on sexual maturation in residents with PFOA water contamination suggested an association between higher PFOA and PFOS concentrations and later age of menarche (Lopez-Espinosa et al., 2011) , and in a study on adult women from the same contaminated water district, increased odds of having experienced menopause were reported to be related with higher PFOA and PFOS levels. Furthermore, indications of an inverse relation between PFOS and estradiol levels were identified in these peri-and post-menopausal women (Knox et al., 2011) .
PFASs are capable of crossing the placental barrier (Midasch et al., 2007; Apelberg et al., 2007a; Gützkow et al., 2012) . The fetus is highly sensitive to toxic exposures (Pryor et al., 2000) and effects of in utero PFAS exposure have been reported (Fei et al., 2007; Apelberg et al., 2007b; Olsen et al., 2009) . This is of special concern since fetal developmental disruptions may have adverse consequences for health later in life (Barker, 2004; Crain et al., 2008; Barouki et al., 2012) . To our knowledge, long-term health effects of prenatal exposure to PFASs on human female reproduction have only been investigated in a study by Christensen et al. (2011) . Using the British ALSPAC cohort, they evaluated PFAS exposure levels in girls who reported age at menarche before 11.5 years compared with controls. The authors concluded that gestational exposure to PFASs did not appear to be associated with earlier age of menarche.
In this study, we aimed to investigate the possible long-term effects of prenatal exposure to PFOA and PFOS on menstrual characteristics, reproductive hormone levels and number of follicles in environmentally exposed women using data from a population-based follow-up study.
Materials and Methods

Population
A Danish pregnancy cohort was established in 1988 -1989 . The study was originally designed to investigate the association between diet during pregnancy and pre-and perinatal outcome measures (Olsen et al., 1995a,b) . Women with uncomplicated pregnancies were recruited at a routine 30th-week visit at a midwifery clinic that covered a geographically welldefined area of the city of Aarhus, Denmark. Women belonging to foreign cultures were not included due to language difficulties (Skajaa et al., 1991) . From a total of 1212 women, 965 (80%) were interviewed and completed a questionnaire. Data were collected on age, parity, height, pre-pregnancy weight, socioeconomic status, and smoking and alcohol habits during pregnancy. Additionally, a serum sample was obtained at the time of enrolment and stored in a bio-bank at 2208C. Perinatal measures were extracted from birth certificates and hospital records (Olsen et al., 1995a,b) . No differences in age, parity, gestational age and birthweight were found between the study population and women who declined to participate. A relatively large proportion of the participants were well-educated women (Skajaa et al., 1991) .
In 2008, follow-up on the female offspring ( 20 years of age) was initiated. Questionnaires were sent to 436 eligible daughters to collect information on lifestyle factors, and general and reproductive health (Fig. 1) . Data included age at menarche and history of hormonal contraceptive use. Three hundred and sixty seven (84% of eligible daughters) answered the questionnaire. In order to further evaluate reproductive function, the daughters were invited to participate in a clinical examination. A total of 267 (61%) daughters agreed to attend the examinations, which were conducted from August 2008 to August 2009.
Maternal serum samples were not available for 19 participants. The final study population consisted of 343 daughters of which 254 had attended the clinical examinations and 89 only had answered the questionnaire. Among the 254 daughters who had attended the examinations, eight women were excluded from the analyses on menstrual cycle length, reproductive hormone levels and follicle number because of breast-feeding (n ¼ 1), signs of premature ovarian failure (n ¼ 1) or due to lack of several key information including use of hormonal contraceptives (n ¼ 6).
Assessment of exposure
Levels of PFOA and PFOS in maternal serum samples from pregnancy week 30 were used as a measure of prenatal exposure. The concentrations of PFOA and PFOS were analysed by column-switching liquid chromatography/tandem mass spectrometry methodology as previously described (Haug et al., 2009) at the Norwegian Institute of Public Health in Oslo, Norway. The lower limit of quantification was 0.05 ng/ml. Sufficient quality of the analytic procedure was ensured by analyses of in-house controls samples. Furthermore, inter-laboratory comparison exercises were performed in which coefficients of variation (depending on the concentration) were 3 -9% and 14-22% for PFOA and PFOS, respectively. The laboratory was blinded to reproductive outcome measures.
Outcome measures
Data on daughters' age at menarche were obtained from the questionnaires as previously reported (Ernst et al., 2012) . The women were asked: 'How old were you when you had your first menstrual bleeding (years and months)?' An age was provided by 337 women, and of these, 175 reported age at menarche in both years and months, whereas 162 only answered in whole years. Since the distribution of age in years was similar between the two groups, the distribution of months was randomly imputed in daughters who reported age only in years.
At the clinical examination, information on menstrual cycle length, cycle day at time of examination and current use of hormonal contraceptives was provided through an interview by a single physician. Both users and non-users of hormonal contraceptives were enrolled into the study. For users, data on menstrual cycle length for statistical analyses were based on information on menstrual pattern prior to commencement of these contraceptives.
Ovarian follicles measuring 2 -9 mm were counted by transvaginal ultrasound using VOLUSON e (GE Healthcare, Zipf, Austria) devices equipped with a 3.7-9.3 MHz transducer as previously reported (Kristensen et al., 2010) . Follicle number used in statistical analyses was calculated as the mean of right and left ovary. If it was not possible to count follicles in both ovaries, the follicle number from only one ovary was used.
Blood samples were obtained between 8:00 and 12:30 h. After centrifugation, serum samples were stored at 2808C until analysis. Immunoassay analyses were performed to measure serum levels of total testosterone, follicle stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (cobas 6000 e 601, Roche Diagnostics, Mannheim, Germany), and sex hormonebinding globulin (SHBG) and dehydroepiandrosterone sulfate (DHEAS) (IMMULITE 2000, Siemens Healthcare, Gwynedd, UK). Concentrations of anti-Müllerian hormone (AMH) were measured using specific ELISA kits (DSL-10-14400; Diagnostic System Laboratories, Inc., Webster, TX, USA). For data included in statistical analyses, measurements below the detection limit (testosterone, n ¼ 2) were set at half the limit (0.10 nmol/l). Free androgen index (FAI) was calculated as 100 × total testosterone (nmol/l)/SHBG (nmol/l).
Statistical analyses
Data were divided into three groups according to tertiles of exposure levels: low (0.1-3.0 ng/ml), medium (3.0-4.3 ng/ml) and high (4.4-19.8 ng/ml) PFOA, and low (2.7-18.0 ng/ml), medium (18.0 -23.6 ng/ml) and high (23.6 -53.1 ng/ml) PFOS, respectively. Differences in descriptive characteristics across exposure groups were analysed using one-way ANOVA test (normal distributed data), Kruskal -Wallis test (skewed data) or x 2 test (dichotomuous data). Outcome variables were age at menarche, menstrual cycle length, number of follicles and levels of reproductive hormones (total testosterone, SHBG, Figure 1 Flowchart. *The final study population comprised these 254 + 89 ¼ 343 women.
Perfluoroalkyl exposure and female reproduction FAI, DHEAS, FSH, LH, estradiol and AMH). When evaluating crude associations between PFAS exposure and daughters' reproductive function, Spearman's rank correlation test was used on untransformed, continuous data.
Multiple linear regression analyses were performed with PFOA or PFOS as categorical explanatory variables (tertiles). Furthermore, adjusted trend tests were conducted with PFOA and PFOS entered as continuous variables in the multiple linear regression model.
Analyses on age of menarche were performed with data on the original scale. The remaining outcome variables were natural log (ln) transformed before analyses to provide an approximate normal distribution of residuals. Covariates were selected a priori based on the literature (Rowland et al., 2002; Karapanou and Papadimitriou 2010; Ernst et al., 2012; Halldorsson et al., 2012) . All factors were included in the regression model without prior testing of changes of estimates. Analyses on age at menarche were adjusted for maternal smoking during pregnancy (yes/no), social class (household income per year .200.000 DKK, yes/no) and daughter's BMI (low: ,18.5 kg/m 2 ; normal: 18.5 -24.9 kg/m 2 ; high: ≥25.0 kg/m 2 ).
Information on daughters' height and weight were provided both in the questionnaire and through standardized anthropometric measurements at the clinical examination. When available, BMI was calculated from height and weight from the clinical examination. For daughters who only answered the questionnaire, calculations of BMI were based on selfreported data. Regression analyses on menstrual cycle length, reproductive hormones and follicle number were adjusted for maternal smoking, social class, daughter's BMI and daughter's smoking (current or occasional smoker/former or never smoker). Furthermore, data on FSH, LH and estradiol were adjusted for cycle phase (follicular/ovulatory/luteal) at the time of examination since blood samples were not drawn at a fixed time of the menstrual cycle. Methods of defining cycle phase in this cohort have been described in details by Ernst et al. (2012) . Based on information on cycle length and cycle day at time of examination, participants were allocated a category of cycle phase (follicular phase: days before ovulation phase; ovulation phase: day of ovulation and one day before and after; luteal phase: the last 13 days of a cycle).
Due to a strong effect of hormonal contraceptives on biochemical and ultrasonographic outcome parameters, analyses on all outcome measures except age at menarche were performed stratifying for current use of hormonal contraceptives. Analyses on FSH, LH and estradiol were only conducted on the group of non-users of hormonal contraceptives.
In our main regression analyses, we allocated missing covariates a category of their own within the covariate in question (Katz, 2011) . In sub-analyses, our analyses were restricted to the smaller group of subjects with available information on all covariates ('complete cases').
We explored possible differences between the three groups of daughters who participated in the clinical examination (n ¼ 267), who only answered the questionnaire (n ¼ 100), and those who did not participate in the followup study (n ¼ 69) (Fig. 1 ). Exposure levels, and maternal and offspring characteristics were compared across the groups using one-way ANOVA test or unpaired t-test for normally distributed data, Kruskal -Wallis or MannWhitney test for skewed data and x 2 test for dichotomuous data.
A P-value of ,0.05 was considered statistically significant. Statistical analyses were performed using Stata software version 12.1 (StataCorp, College Station, TX, USA).
Ethical approval
The study was approved by the local ethical committee of Central Denmark Region (registration number M-20070157) and informed written consent was obtained from all of the participants before clinical examination.
Results
At the time of enrolment, the daughters had a mean (SD) age of 19.6 (0.4) years. Concentrations of PFOA and PFOS were measurable in all available maternal serum samples. Median (inter-quartile range) PFOA and PFOS were 3.6 (2.8-4.8) ng/ml and 21.1 (16.7-25.5) ng/ml, respectively. Characteristics of the study population according to tertiles of exposure levels of PFOA and PFOS are presented in Table 1 . Daughters exposed to higher levels of PFOA in utero had higher BMI, were more likely to be users of hormonal contraceptives and were born of younger mothers compared with women exposed to lower levels of PFOA. Daughters with higher serum PFOA or PFOS exposure were more often the first born child compared with daughters with lower exposure levels.
A total of 337 women provided an age of menarche and mean (SD) age of menarche was 13.2 (1.3) years. Results from analyses on age of menarche are presented in Table 2 . Crude means (SD) age of menarche in the three exposure groups of PFOA (low, medium, high) were 13.1 (1.3) years, 13.2 (1.1) years and 13.5 (1.3) years. In the adjusted regression analyses, women exposed to high levels of PFOA had 5.3 [95% confidence interval (95% CI): 1.3; 9.3] months later age at the first menstrual bleeding compared with the reference group of low PFOA. Crude (P ¼ 0.05) and adjusted (P ¼ 0.01) trend tests also indicated a relationship between higher prenatal exposure to PFOA and later age of menarche. No association was found between prenatal exposure to PFOS and age of menarche.
No statistically significant relationships were found between PFOA or PFOS exposure and cycle length, reproductive hormone levels and number of follicles in the subgroup of daughters who participated in the clinical examination. One hundred and seventy one (70%) of these women were users of hormonal contraceptives and 75 (30%) were non-users. Crude medians and results from trend tests are presented in Tables 3 and 4. When performing additional regression analyses on 'complete cases', the b-coefficients in adjusted trend tests on PFOS exposure and FSH and LH levels were markedly reduced to 0.002 (95% CI: 20.014; 0.019), P ¼ 0.79 and 0.010 (95% CI: 20.014; 0.035), P ¼ 0.41, respectively, compared with 0.010 (95% CI: 20.003; 0.023), P ¼ 0.14 and 0.016 (95% CI: 20.006; 0.039), P ¼ 0.15 in the main analyses (Table 4) . Complete case analyses on FSH and LH were restricted to 52 subjects, whereas 74 women were included in the main analyses. Results on all other outcome measures were substantially unchanged.
Maternal serum levels of PFOA and PFOS were highly correlated (Spearman's rho ¼ 0.64, P , 0.0001) and the possible effect of co-exposure was evaluated in sub-analyses. The estimates on the association between PFOA exposure and age of menarche were essentially unchanged when adjusting for PFOS levels (data not shown).
When evaluating the original cohort of all eligible daughters, there were no differences in maternal serum concentrations of PFOA or PFOS between daughters who participated in the clinical examination, who only completed the questionnaire or those who did not participate in follow-up (Table 5) . Furthermore, there were no statistically significant differences in maternal age, pre-pregnancy BMI, parity, social class or daughters' birthweight across the three groups. However, maternal alcohol consumption was lower and there were a higher proportion of smokers among mothers of non-participants. Daughters who participated in the examination had lower BMI compared with women who only completed the questionnaire. Regarding age at menarche, smoking habits and use of hormonal contraceptives the two groups of daughters were comparable.
Discussion
To the best of our knowledge, this is the first population-based follow-up study investigating the possible long-term effects of in utero exposure to PFOA and PFOS on several female reproductive outcome measures. We found a statistically significant association between prenatal exposure to PFOA and later age of menarche with a difference of 5.3 months between lowest and highest tertile of maternal PFOA concentration.
No association between PFOS and age of menarche was found and we observed no effects of any of the two PFASs on menstrual cycle length, follicle number and reproductive hormone concentrations. The possible long-term effect of gestational exposure to PFASs on the timing of puberty has previously only been investigated in a nested casecontrol study by Christensen et al. (2011) . Self-reports of pubertal development were prospectively collected through questionnaires at the age of 8, 9, 10, 11 and 13 years and 218 cases of 'earlier' menarche (defined as menarche before age 11.5 years) and 230 controls were selected among 5756 female offspring in the UK ALSPAC cohort. No statistically significant association between prenatal PFOA exposure and age of menarche was found. Both the present study and the study by Christensen et al. used data from a cohort of environmentally exposed women with prenatal exposure measured in maternal serum and self-reported age at menarche as marker of pubertal development. The exposure levels of PFOA were fully comparable in the two populations (median PFOA were 3.7 ng/ml in the study by Christensen et al. and 3.6 ng/ml in the present study) and the ethnic background of the vast majority of the women was Caucasian. Hence, discrepancies in the findings between the two studies could primarily be explained by differences in methods of collecting data on age of menarche and in statistical approach including definition of outcome. It should be noted that Christensen et al. defined the outcome on age of menarche with a cut-off value at 11.5 years and thus focused on early menarche. In our study, only 7% of the participants had reached menarche at that age.
The result in our study on an association between exposure to PFOA and delay in age of menarche is supported by findings from a crosssectional study on a population exposed to very high levels of PFOA (median of 20 ng/ml) (Lopez-Espinosa et al., 2011). Information on current exposure levels and menarcheal status was collected among 2903 girls aged 8-18 years who were residents in a contaminated water area surrounding a chemical plant. Higher levels of PFOA were found to be associated with reduced odds of having reached menarche with a difference of 130 days between highest and lowest exposure quartile.
In our study, we aimed to investigate the hypothesis of an effect of prenatal PFAS exposure. It cannot be excluded that our finding of an association between PFOA exposure and delay in menarche is partly or completely a result of post-natal exposure. Due to the exposure routes through dietary intake and indoor environment (Haug et al., 2011) it must be expected that serum levels of PFOA are strongly correlated within family members. Hence, daughters who were highly exposed during prenatal life are also expected to be highly exposed in childhood and adolescence. It is not possible to separate the influence of prenatal and post-natal exposure in either the present study or the study by Lopez-Espinosa et al. Late menarche has been reported to be associated with lower bone mineral density, which is partly explained by shorter duration of exposure to endogenous estrogens. Furthermore, late menarcheal age may have psychosocial consequences (Karapanou and Papadimitriou, 2010) . Whether a delay in menarche of a few months as found in our study and in the study by Lopez-Espinosa et al. has clinically important long-term health implications has yet to be determined (Lopez-Espinosa et al., 2011) . Regarding possible consequences of delayed menarche for reproductive health in adulthood, the relationship with PFOA exposure and age at menarche was not reflected in an association between PFOA and the remaining reproductive outcome measures in the present study.
The onset of pubertal maturation is regulated by hypothalamic secretion of gonadotrophin-releasing hormone. Subsequent pituitary gonadotrophin production is necessary for normal gonadal development and function (Karapanou and Papadimitriou, 2010) . Gonadotrophins stimulate ovarian estradiol production which initiates maturation of endometrial tissue and menarche occurs 2 years after pubertal onset. Several ) and daughter's smoking (current or occasional smoker/former or never smoker). FSH, LH and estradiol were additionally adjusted for menstrual cycle phase (follicular/ovulatory/ luteal).
environmental compounds have been reported to interfere with the timing of puberty, primarily in the direction of accelerated development (Crain et al., 2008) . Disruptions have been suggested to be either central with interference of hypothalamic -pituitary function or peripheral with direct effects on reproductive tissue or other target cells. In peripheral tissue, a variety of possible actions of endocrine disrupters include direct hormonal effect, modification of hormone receptor binding or alteration of the availability of naturally occurring hormones through disruption of synthesis, transport or metabolism (Caserta et al., 2008; Crain et al., 2008) . The underlying mechanism for a possible effect of PFAS exposure on the human reproductive system remains to be fully established.
The major strength of this study is the longitudinal design. We were able to evaluate the possible long-term effects of prenatal exposure to PFASs on several reproductive outcome measures and had information on important covariates. Our source population was environmentally exposed women from the general population and we had a high participation rate both at enrolment of the mothers (80%) and at follow-up of the daughters (84% answered questionnaire). Furthermore, very few maternal serum samples were missing (5%) and the exposure levels of PFOA and PFOS were measurable in all available samples.
Limitations in this study include a risk of selection bias which would be present if participation depended on PFAS exposure and reproductive outcome measures. As previously reported by Halldorsson et al. (2012) and as depicted in Table 5 , losses during follow-up were not associated with exposure levels, since no differences were observed in maternal PFAS levels of the three groups of offspring who did not participate in follow-up, who completed the questionnaire only, or who participated in the clinical examination. Regarding outcome measures, a total of 337 women (77% of those originally invited to participate) had provided an age of menarche and due to this relatively high participation rate we believe that selection bias could not have affected our estimate on this outcome substantially. However, the available number of observations was reduced in the analyses based on clinical examinations (34-56%, depending on outcome measure) and there may be some important differences in characteristics (e.g. lifestyle) of women who accepted and those who declined participation in the clinical examinations.
Another limitation in our study is that data on age at menarche were collected retrospectively. This recall method is in general considered to be the less valid than the prospective method where premenarcheal girls are followed regularly or the 'status quo' method where information on menarche is obtained by asking a group of girls and adolescents whether they have had their first menstrual bleeding at the time of assessment and furthermore obtain exact information on age (Karapanou and Papadimitriou, 2010) . The latter method requires a large sample size and the age range should be around 8 -16 years. We did not have the opportunity to use either the prospective or the status quo method. The age of our participants ranged from 19 to 21 years. This should be an appropriate time to obtain information on age at menarche by the recall method since all participants had experienced their first menstrual bleeding and the time period since the event was relatively short (2-10 years). However, even for a time span of decades, recollection of age of menarche has been demonstrated to be both precise and without bias (Must et al., 2002) . We found a mean age of menarche of 13.2 years which is comparable with findings from other Danish studies (Helm and Grøn-lund, 1998; Aksglaede et al., 2009) supporting the reliability of our data. Furthermore, our participants were without knowledge of their prenatal PFAS exposure levels when reporting age of menarche. Hence, a possible misclassification was unrelated to exposure status and would most likely lead to an underestimation of the true association. Concerns exist regarding fetal exposure to toxic compounds due to a high vulnerability in this early life stage (Pryor et al., 2000) . We did not have the opportunity to measure the exact amount of PFASs to which the subjects had been exposed in utero. Instead we used PFAS concentrations in maternal serum, which should be applicable surrogates for fetal exposure, since both PFOS and PFOA are efficiently transferred to the fetus via placenta (Midasch et al., 2007; Gützkow et al., 2012) . PFOA may pass the placenta barrier more easily compared with PFOS (Fei et al., 2007; Gützkow et al., 2012) . This could partly explain why only PFOA levels were associated with age at menarche. In accordance with this, only PFOA levels were related to markers of reproductive health in male offspring from the same cohort (Vested et al., 2013) . However, these findings may also be explained by differences between PFOA and PFOS in modes of action or be due to unknown factors.
We measured exposure levels of PFASs in pregnancy week 30. PFOA and PFOS have long half-lives of 4 -5 years in humans (Lau et al., 2007; Olsen et al., 2009 ) and serum levels measured at different time points in pregnancy are highly correlated (Fei et al., 2007) . Consequently, we believe that fetal exposure to PFASs in pregnancy week 30 reflects the degree of exposure during critical windows of development in early pregnancy (Pryor et al., 2000) . However, the levels of PFASs in maternal serum have been reported to decline during pregnancy (Fei et al., 2007; Fromme et al., 2010) . PFASs are bound to plasma proteins (Han et al., 2003) and since plasma volume expands throughout pregnancy (Frederiksen, 2001) , maternal serum concentration of PFASs may decrease as a consequence of dilution. Though our results on PFOA exposure and later age of menarche were robust in sub-analyses including maternal serum albumin and gestational weight gain in pregnancy week 30 as covariates (data not shown), we cannot exclude that some maternal inter-individual differences in physiological gestational changes may have confounded our results if these factors were related to reproductive outcome of the daughters.
We found no association between prenatal exposure to PFASs and cycle length, reproductive hormone levels, and follicle number but we cannot rule out that PFAS exposure to some extend may affect these parameters. The probability of detecting a true association between PFAS exposure and these variables may have been reduced by several factors. Information on the outcome measures depended on participation in the clinical examination and hence the analyses were restricted to a subset of women. Statistical power was further reduced due to stratification by hormonal contraceptive use. Information on menstrual cycle length were based on self-reports and particularly for users of hormonal contraceptives recalled data on cycle length may have been imprecise (Must et al., 2002; Small et al., 2007) . Furthermore, relationships between PFAS exposure and levels of reproductive hormones among hormonal contraceptive users may have been blurred by actions of exogenous hormones.
In conclusion, we found an association between in utero exposure to PFOA and delay in self-reported age at menarche which may indicate effects of prenatal exposure to PFASs on female reproductive function. However, we saw no statistically significant associations between PFAS exposure and menstrual cycle length, reproductive hormone levels or number of antral follicles in young adulthood. No causal inferences can be made on the basis of this study and further studies are needed to confirm the result and to elaborate on the underlying mechanisms for possible effects of prenatal PFAS exposure.
